Eva Szegezdi

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2026
Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma.

|Jul 21, 2025
Disrupting membranes, controlling cell fate: the role of pore-forming proteins in cell death and therapy.

Sonia Iranpour, Maryam Arif, Eva Szegezdi

|Jun 12, 2025
Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma.

Xuechun Wang, Loan Duong, Yujing Qin

|Jul 16, 2020
Aspartic Aminopeptidase Is a Novel Biomarker of Aggressive Chronic Lymphocytic Leukemia.

Pramath Kakodkar, Sanket More, Kinga András

Pageof 1